(Q40408396)
Statements
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial (English)
Achim Rittmeyer
Fabrice Barlesi
Daniel Waterkamp
Keunchil Park
Joachim von Pawel
Shirish M Gadgeel
Toyoaki Hida
Manuel Cobo Dols
Joseph Leach
Jonathan Polikoff
Carlos Barrios
Fairooz Kabbinavar
Osvaldo Arén Frontera
Filippo De Marinis
Hande Turna
Jong-Seok Lee
Marcus Ballinger
Marcin Kowanetz
Pei He
Alan Sandler
OAK Study Group
Fortunato Ciardiello
David R Gandara
13 December 2016